Last updated on: 11/12/2019
1. Contact details
This data source is maintained by the following centre registered in the ENCePP inventory of research centres: MFIR-Ulster
Name of data sourceEUROmediCAT central database
Name under which the data source should be displayed in the inventory (e.g short name if one exists)EUROmediCAT
Name of organisation
1) Department/research groupCentre for Maternal, Fetal and Infant Research
2) Organisation/affiliationUniversity of Ulster
Administrative Contact
Title Mrs
Last name Taylor
First name Alyson
Address line 1Shore Rd
Address line 2Newtownabbey
Address line 3
CityCo Antrim
PostcodeBT37 0QB
CountryUnited Kingdom
Scientific Contact
Title Professor
Last name Dolk
First name Helen
Address line 1Shore Road
Address line 2Newtownabbey
Address line 3
CityCo Antrim
PostcodeBT37 0QB
CountryUnited Kingdom
2. Description/category
Disease/case registry
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
OTC
Vaccines
Prescribed medications taken by
mother prior to and during pregnancy
3.2 ATC code (5th level)
Yes
3.3 Other product dictionaries
No
3.4 Recording of indication for use
Yes
Is a coding dictionary being used? WHO ICD classification
4. Coverage of events
Event
Dictionary
Dictionary details
Adverse events (for pharmacovigilance databases)
Yes
Prior to or during pregnancy WHO ICD classification
Diagnosis in primary care
Yes
WHO ICD classification
Specialist diagnosis
Yes
WHO ICD classification
Discharge diagnosis
Yes
WHO ICD classification
Overdoses
Yes
WHO ICD classification
Teratogenic events
Yes
WHO ICD classification
5. Year of establishment
2011
6. Geographical origin of data
EEA/EFTA countries
Belgium
Croatia
Denmark
France
Germany
Ireland
Italy
Malta
Netherlands
Norway
Poland
Spain
Switzerland
United Kingdom
Non EEA/EFTA areas
Non EEA Europe (excluding Russia & former Soviet Republics)
7. Demographical extent of data collection
Regional sub-set :
Some countries have a national registry which cover the entire country; others are restricted to a specific population region within the country
8. Age groups
17 years and under [Paediatrics]
preterm newborn infants
term newborn infants (0 to 27 days)
infants and toddlers (28 days to 23 months)
children (2 to 11 years)
9. Size of the source/catchment population
8,800,000
10 a. Total (cumulative) number of persons with actual data
26,950
10 b. Number of persons with active data collection in past calendar year
588
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
Yes :
Some registries can link their congenital anomaly data to local prescription or administrative databases in order to obtain more accurate information on medications dispensed during pregnancy.
Data have also been previously linked to diabetic cohorts and population cohorts.
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
Yes
15. Charge/fee for data access
Yes
Special arrangements for academic purposes:
Yes
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
Garne E, Vinkel Hansen A, Morris J, Zaupper L, Addor M-C, Barisic I, Gatt M, Lelong N, Klungsoyr K, O'Mahony M, Nelen V, Neville A, Pierini A, Tucker D, de Walle H, Wiesel A, Loane M and Dolk H (2015). Use of asthma-medication during pregnancy and risk of specific congenital anomalies - A European case-malformed control study. Journal of Allergy and Clinical Immunology, DOI:10.1016/j.jaci.2015.05.043 http://www.EUROmediCAT.eu/publicationsandpresentations/publications
Charlton R, Jordan S, Pierini A, Garne E, Neville A, Hansen A, Gini R, Thayer D, Tingay K, Puccini A, Bos H, Nybo Andersen A, Sinclair M, Dolk H, de Jong-van den Berg L (2014). Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions. BJOG 23 (6): 1010-1020. DOI: 10.1111/1471-0528.13143)http://www.EUROmediCAT.eu/publicationsandpresentations/publications
de Jong L, Garne E, Gini R, Jordan SE, Klungsoyr K, Loane M, Neville AJ, Pierini A, Puccini A, Thayer DS, Tucker D, Vinkel Hansen A, Bakker MK (2015). Improving information on maternal medication use by linking prescription data to congenital anomaly registers: A EUROmediCAT Study, Drug Safety. DOI: 10.1007/s40264-015-0321-9 http://www.EUROmediCAT.eu/publicationsandpresentations/publications
Luteijn JM, Addor M-C, Arriola L, Bianchi F, Garne E, Khoshnood B, Nelen V, Neville A, Queisser-Luft A, Rankin J, Rounding C, Verellen-Dumoulin C, de Walle H, Wellesley D, Wreyford B, Yevtushok L, de Jong-van den Berg L, Morris J and Dolk H (2015). The effect of H1N1 pandemic influenza on congenital anomaly prevalence in Europe: an ecological time series study. Epidemiology 26 (6) 853-861http://www.EUROmediCAT.eu/publicationsandpresentations/publications
Dolk H, de Jong-van den Berg LTW, Pierini A, Morris J, Bakker M, Jordan S, Garne E, Klungsoyr K, Loane M, Charlton R, Luteijn JM, Sinclair M, Latos-Bielenska A (2015). Oral Presentation and Poster Abstracts of the EUROmediCAT Conference, February 2015, Poznan, Poland. Pharmacoepidemiology & Drug Safety. DOI: 10.1002/pds.3865
http://www.EUROmediCAT.eu/publicationsandpresentations/publications
